Relationship between the prohibitin 3' untranslated region C > T gene polymorphism and cancer susceptibility - Results of a meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3319-3323

  Zhou, Tian Biao ^a,b   Yin, Sheng Sheng ^b   Huang, Jian Jian ^c   Ou, Chao ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^c HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

3' untranslated region; Breast cancer; C > T gene polymorphism; Meta analysis; Ovarian cancer; Prohibitin

Indexed keywords

EID: 84873573897     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3319     Document Type: Article

References (36)

1. Alshatwi AA, Shafi G, Hasan TN, et al (2011). Apoptosis-mediated inhibition of human breast cancer cell proliferation by lemon citrus extract. Asian Pac J Cancer Prev, 12, 1555-9.
2. Altus MS, Wood CM, Stewart DA, et al (1995). Regions of evolutionary conservation between the rat and human prohibitin-encoding genes. Gene, 158, 291-4.
3. Arisawa T, Tahara T, Shiroeda H, et al (2012). Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3'-UTR, influence susceptibility to gastric cancer. Hum Immunol, 73, 747-52.
4. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
5. Campbell IG, Allen J, Eccles DM (2003). Prohibitin 3' untranslated region polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 12, 1273-4.
6. Egger M, Davey SG, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
7. Gao CM, Tajima K, Ding JH, et al (2009). Body size, physical activity and risk of breast cancer - a case control study in Jangsu Province of China. Asian Pac J Cancer Prev, 10, 877-81.
8. Gao S, Liu N, Ma Y, et al (2012). Methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers in ovarian cancer risk. Asian Pac J Cancer Prev, 13, 569-73.
9. Grimm C, Polterauer S, Zeillinger R, et al (2008). The prohibitin 3' untranslated region polymorphism in patients with ovarian cancer. Eur J Obstet Gynecol Reprod Biol, 137, 236-9.
10. Huo X, Lu C, Huang X, et al (2009). Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women. J Cancer Res Clin Oncol, 135, 1569-75.
11. Jakubowska A, Gronwald J, Gorski B, et al (2007). The 3' untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation. Breast Cancer Res Treat, 104, 67-74.
12. Jakubowska A, Gronwald J, Menkiszak J, et al (2008). Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism. BMC Cancer, 8, 90.
13. Jeon S, Choi JY, Lee KM, et al (2010). Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer. Breast Cancer Res Treat, 121, 737-42.
14. Jeschke J, Van Neste L, Glockner SC, et al (2012). Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen. Epigenetics, 7, 7.
15. Karakus N, Kara N, Ulusoy AN (2008). Lack of association between prohibitin 3' untranslated region C-->T polymorphism and breast cancer in a Turkish population. DNA Cell Biol, 27, 449-52.
16. Kermani IA, Kojidi HT, Gharamaleki JV, et al (2011). Association of serum level of 25 hydroxy-vitamin D with prognostic factors for breast cancer. Asian Pac J Cancer Prev, 12, 1381-4.
17. Khokher S, Qureshi MU, Riaz M, Akhtar N, Saleem A (2012). Clinicopathologic profile of breast cancer patients in pakistan: ten years data of a local cancer hospital. Asian Pac J Cancer Prev, 13, 693-8.
18. Li QF, Liang Y, Shi SL, et al (2011). Localization of prohibitin in the nuclear matrix and alteration of its expression during differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid. Cell Mol Neurobiol, 31, 203-11.
19. Luparello C, Longo A, Vetrano M (2012). Exposure to cadmium chloride influences astrocyte-elevated gene-1 (AEG-1) expression in MDA-MB231 human breast cancer cells. Biochimie, 94, 207-13.
20. Manjeshwar S, Branam DE, Lerner MR, et al (2003). Tumor suppression by the prohibitin gene 3'untranslated region RNA in human breast cancer. Cancer Res, 63, 5251-6.
21. Nadimpalli R, Yalpani N, Johal GS, et al (2000). Prohibitins, stomatins, and plant disease response genes compose a protein superfamily that controls cell proliferation, ion channel regulation, and death. J Biol Chem, 275, 29579-86.
22. Sagae S, Mori M, Moore MA (2002). Risk Factors for Ovarian Cancers: Do Subtypes Require Separate Treatment in Epidemiological Studies? Asian Pac J Cancer Prev, 3, 5-16.
23. Spurdle AB, Purdie DM, Chen X, et al (2003). The prohibitin 3' untranslated region polymorphism is not associated with risk of ovarian cancer. Gynecol Oncol, 90, 145-9.
24. Szabova L, Yin C, Bupp S, et al (2012). Perturbation of Rb, p53 and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer. Cancer Res, doi: 10.1158/0008- 5472.CAN-11-3834.
25. Vijayaraman KP, Veluchamy M, Murugesan P, et al (2012) p53 Exon 4 (codon 72) Polymorphism and Exon 7 (codon 249) Mutation in Breast Cancer Patients in Southern Region (Madurai) of Tamil Nadu. Asian Pac J Cancer Prev, 13, 511-6.
26. Wang T, Li QH, Hao GP, et al (2010). Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo. Asian Pac J Cancer Prev, 11, 193-200.
27. Xu L, Ju XB, Li P, et al (2012) Association Between the Ku70- 1310C/G Promoter Polymorphism and Cancer Risk: a Meta-analysis. Asian Pac J Cancer Prev, 13, 683-7.
28. Xu X, Ren H, Zhou B, et al (2012). Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients. Lung Cancer, 77, 438-42.
29. Yip CH, Anderson BO (2007). The Breast Health Global Initiative: clinical practice guidelines for management of breast cancer in low- and middle-income countries. Expert Rev Anticancer Ther, 7, 1095-104.
30. Yip CH, Taib NA, Choo WY, et al (2009). Clinical and pathologic differences between BRCA1-, BRCA2-, and non-BRCA-associated breast cancers in a multiracial developing country. World J Surg, 33, 2077-81.
31. Yip CH, Taib NA, Mohamed I (2006). Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev, 7, 369-74.
32. Zhang Y, Xu B, Liu Y, et al (2012). The ovarian cancer-derived secretory/releasing proteome: a repertoire of tumor markers. Proteomics, 12, 1883-91.
33. Zhou TB, Liu YG, Lin N, et al (2012). Relationship Between Angiotensin-converting Enzyme Insertion/Deletion Gene Polymorphism and Systemic Lupus Erythematosus/Lupus Nephritis: A Systematic Review and Metaanalysis. J Rheumatol, 39, 686-93.
34. Zhou TB, Qin YH, Su LN, et al (2011). ACE I/D gene polymorphism can't predict the steroid responsiveness in Asian children with idiopathic nephrotic syndrome: a meta-analysis. PLoS One, 6, 19599.
35. Zhou TB, Qin YH, Su LN, et al (2011). Insertion/deletion (I/D) polymorphism of angiotensin-converting enzyme gene in steroid-resistant nephrotic syndrome for children: a genetic association study and meta-analysis. Ren Fail, 33, 741-8.
36. Zhou TB, Qin YH, Su LN, et al (2011). The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: a systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst, 12, 624-33.